Follow this preprint

Evolocumab as an immunomodulator in glioma: A window of opportunity trial evaluating PCSK9 inhibition to enhance surface MHC-I on tumor

Kirit Singh, Matthew W. Foster, Marlene J. Violette, Kelly M. Hotchkiss, Chelsea O. Railton, Emily E. Blandford, Kathryn E. Blethen, Elizabeth L. Thomas, David M. Ashley, Annick Desjardins, Henry S. Friedman, Margaret O. Johnson, Allan Friedman, Stephen Keir, Evan D. Buckley, James E. Herndon, Roger E. McLendon, John H. Sampson, Evan Calabrese, Giselle Y. Lopez, Gerald A. Grant, Anoop P. Patel, Chuan-Yuan Li, Peter E. Fecci, Mustafa Khasraw
doi: https://doi.org/10.1101/2024.06.19.24309192
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article usage

Article usage: June 2024 to April 2025

Show by monthAbstractFull-text HTMLPDF
Total                  1,121230487
Tweeted by 7
Back to top
Posted June 20, 2024.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
Evolocumab as an immunomodulator in glioma: A window of opportunity trial evaluating PCSK9 inhibition to enhance surface MHC-I on tumor
Kirit Singh, Matthew W. Foster, Marlene J. Violette, Kelly M. Hotchkiss, Chelsea O. Railton, Emily E. Blandford, Kathryn E. Blethen, Elizabeth L. Thomas, David M. Ashley, Annick Desjardins, Henry S. Friedman, Margaret O. Johnson, Allan Friedman, Stephen Keir, Evan D. Buckley, James E. Herndon, Roger E. McLendon, John H. Sampson, Evan Calabrese, Giselle Y. Lopez, Gerald A. Grant, Anoop P. Patel, Chuan-Yuan Li, Peter E. Fecci, Mustafa Khasraw
medRxiv 2024.06.19.24309192; doi: https://doi.org/10.1101/2024.06.19.24309192
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.